RIPK3 deficiency could ameliorate myocardial injury in mice with cardiac hypertrophy, improve cardiac function, inhibit CaMKII activation, correct CaMKIIδ alternative splicing disorder, and reduce necrosis. Here, CAMK2G is linked to cardiac hypertrophy.